Literature DB >> 16227207

Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules.

Véronique Rossi1, Florence Teillet, Nicole M Thielens, Isabelle Bally, Gérard J Arlaud.   

Abstract

C1s and mannan-binding lectin-associated serine protease-2 (MASP-2) are the proteases that trigger the classical and lectin pathways of complement, respectively. They have identical modular architectures and cleave the same substrates, C2 and C4, but show markedly different efficiencies toward C4. Multisite-directed mutagenesis was used to engineer hybrid C1s/MASP-2 molecules where either the complement control protein (CCP) modules or the serine protease (SP) domain of C1s were swapped for their MASP-2 counterparts. The resulting chimeras (C1s(MASP-2 CCP1/2) and C1s(MASP-2 SP), respectively) were expressed and characterized chemically and functionally. Whereas C1s(MASP-2 SP) was recovered as an active enzyme, C1s(MASP-2 CCP1/2) was produced in a proenzyme form and was susceptible to activation by C1r, indicating that the activation properties of the chimeras were dictated by the nature of their SP domain. Similarly, each activated chimera had an esterolytic activity characteristic of its own SP domain and cleaved C2 with an efficiency comparable with that of their parent C1s and MASP-2 proteases. Both chimeras cleaved C4, but whereas C1s(MASP-2 SP) and C1s had Km values in the micromolar range, C1s(MASP-2 CCP1/2) and MASP-2 had Km values in the nanomolar range, resulting in 21-27-fold higher kcat/Km ratios. Thus, the higher C4 cleavage efficiency of MASP-2 arises from a higher substrate recognition efficacy of its CCP modules. Remarkably, C1s(MASP-2 CCP1/2) retained C1s ability to associate with C1r and C1q to form a pseudo-C1 complex and to undergo activation within this complex, indicating that the C1s-CCP modules have no direct implication in either function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227207     DOI: 10.1074/jbc.M503813200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Structural basis for activation of the complement system by component C4 cleavage.

Authors:  Rune T Kidmose; Nick S Laursen; József Dobó; Troels R Kjaer; Sofia Sirotkina; Laure Yatime; Lars Sottrup-Jensen; Steffen Thiel; Péter Gál; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

Review 3.  Disease-causing mutations in genes of the complement system.

Authors:  Søren E Degn; Jens C Jensenius; Steffen Thiel
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

Review 4.  Complement activation and cardiac surgery: a novel target for improving outcomes.

Authors:  Gregory L Stahl; Stanton K Shernan; Peter K Smith; Jerrold H Levy
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

5.  The role of the lys628 (192) residue of the complement protease, c1s, in interacting with Peptide and protein substrates.

Authors:  Lakshmi Carmel Wijeyewickrema; Renee Charlene Duncan; Robert Neil Pike
Journal:  Front Immunol       Date:  2014-09-17       Impact factor: 7.561

Review 6.  Deciphering the fine details of c1 assembly and activation mechanisms: "mission impossible"?

Authors:  Christine Gaboriaud; Wai Li Ling; Nicole M Thielens; Isabelle Bally; Véronique Rossi
Journal:  Front Immunol       Date:  2014-11-06       Impact factor: 7.561

7.  Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants.

Authors:  Isabelle Bally; Antonio Inforzato; Fabien Dalonneau; Matteo Stravalaci; Barbara Bottazzi; Christine Gaboriaud; Nicole M Thielens
Journal:  Front Immunol       Date:  2019-03-14       Impact factor: 7.561

8.  Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens.

Authors:  Nehemiah T Zewde; Rohaine V Hsu; Dimitrios Morikis; Giulia Palermo
Journal:  Front Phys       Date:  2021-04-29

Review 9.  The complement system in ischemia-reperfusion injuries.

Authors:  William B Gorsuch; Elvina Chrysanthou; Wilhelm J Schwaeble; Gregory L Stahl
Journal:  Immunobiology       Date:  2012-08-07       Impact factor: 3.144

Review 10.  Paths reunited: Initiation of the classical and lectin pathways of complement activation.

Authors:  Russell Wallis; Daniel A Mitchell; Ralf Schmid; Wilhelm J Schwaeble; Anthony H Keeble
Journal:  Immunobiology       Date:  2009-09-27       Impact factor: 3.144

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.